MCID: HYP036
MIFTS: 41

Hyperlysinemia malady

Genetic diseases, Rare diseases, Metabolic diseases categories

Aliases & Classifications for Hyperlysinemia

About this section
Sources:
49OMIM, 10Disease Ontology, 11diseasecard, 45NIH Rare Diseases, 22GeneTests, 23Genetics Home Reference, 12DISEASES, 51Orphanet, 24GTR, 65UMLS, 36MeSH, 67UniProtKB/Swiss-Prot, 59SNOMED-CT, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet, 34MedGen
See all sources

Aliases & Descriptions for Hyperlysinemia:

Name: Hyperlysinemia 49 10 11 45 22 23 12 51 24
Lysine Intolerance 45 22 65 67
Lysine Alpha-Ketoglutarate Reductase Deficiency Disease 23 65
Alpha-Aminoadipic Semialdehyde Synthase Deficiency 45 67
Alpha-Aminoadipic Semialdehyde Deficiency Disease 23 65
Lysine Alpha-Ketoglutarate Reductase Deficiency 45 51
Hyperlysinemia Type I 51 67
Hyperlysinemias 65 36
Saccharopinuria 23 65
 
Lysine:alpha-Ketoglutarate Reductase Deficiency 67
Saccharopine Dehydrogenase Deficiency Disease 23
L-Lysine:nad-Oxido-Reductase Deficiency 67
L-Lysine Nad-Oxido-Reductase Deficiency 45
Saccharopine Dehydrogenase Deficiency 65
Familial Hyperlysinemia 23
Hyperlysinemia, 1 67
Hyplys1 67


Classifications:



Characteristics (Orphanet epidemiological data):

51
hyperlysinemia:
Inheritance: Autosomal recessive; Age of onset: All ages; Age of death: any age


External Ids:

OMIM49 238700
Disease Ontology10 DOID:9274
MeSH36 D020167
Orphanet51 2203
SNOMED-CT59 58558003
ICD10 via Orphanet28 E72.3
MESH via Orphanet37 D020167
UMLS via Orphanet66 C0268553, C0936256

Summaries for Hyperlysinemia

About this section
OMIM:49 Hyperlysinemia type I is an autosomal recessive metabolic condition with variable clinical features. Some patients who... (238700) more...

MalaCards based summary: Hyperlysinemia, also known as lysine intolerance, is related to 2,4-dienoyl-coa reductase deficiency and citrullinemia, and has symptoms including autosomal recessive inheritance, abnormality of the genitourinary system and short attention span. An important gene associated with Hyperlysinemia is AASS (Aminoadipate-Semialdehyde Synthase), and among its related pathways are and Carbon metabolism.

Disease Ontology:10 An amino acid metabolic disorder that involves an abnormal increase of lysine in the blood.

NIH Rare Diseases:45 Hyperlysinemia is an inherited condition characterized by elevated blood levels of the amino acid lysine. hyperlysinemia typically causes no health problems, and most people with elevated lysine levels are unaware that they have this condition. rarely, people with hyperlysinemia have intellectual disability or behavioral problems. hyperlysinemia is caused by mutations in the aass gene. it has an autosomal recessive pattern of inheritance. last updated: 1/28/2013

Genetics Home Reference:23 Hyperlysinemia is an inherited condition characterized by elevated blood levels of the amino acid lysine, a building block of most proteins. Hyperlysinemia is caused by the shortage (deficiency) of the enzyme that breaks down lysine. Hyperlysinemia typically causes no health problems, and most people with elevated lysine levels are unaware that they have this condition. Rarely, people with hyperlysinemia have intellectual disability or behavioral problems. It is not clear whether these problems are due to hyperlysinemia or another cause.

UniProtKB/Swiss-Prot:67 Hyperlysinemia, 1: An autosomal recessive metabolic condition with variable clinical features. Some patients present with non-specific seizures, hypotonia, or mildly delayed psychomotor development, and increased serum lysine and pipecolic acid on laboratory analysis. However, about half of the probands are reported to be asymptomatic, and hyperlysinemia is generally considered to be a benign metabolic variant.

Wikipedia:68 Hyperlysinemia is an autosomal recessivemetabolic disorder characterized by an abnormal increase of... more...

Related Diseases for Hyperlysinemia

About this section

Graphical network of diseases related to Hyperlysinemia:



Diseases related to hyperlysinemia

Symptoms for Hyperlysinemia

About this section

Symptoms by clinical synopsis from OMIM:

238700

Clinical features from OMIM:

238700

HPO human phenotypes related to Hyperlysinemia:

(show all 14)
id Description Frequency HPO Source Accession
1 autosomal recessive inheritance HP:0000007
2 abnormality of the genitourinary system HP:0000119
3 short attention span HP:0000736
4 delayed speech and language development HP:0000750
5 hyperactivity HP:0000752
6 ectopia lentis HP:0001083
7 intellectual disability HP:0001249
8 seizures HP:0001250
9 muscular hypotonia HP:0001252
10 anemia HP:0001903
11 hyperlysinemia HP:0002161
12 infantile onset HP:0003593
13 phenotypic variability HP:0003812
14 cognitive impairment HP:0100543

Drugs & Therapeutics for Hyperlysinemia

About this section

Interventional clinical trials:

Search ClinicalTrials, NIH Clinical Center for Hyperlysinemia


Cochrane evidence based reviews: Hyperlysinemias

Genetic Tests for Hyperlysinemia

About this section

Genetic tests related to Hyperlysinemia:

id Genetic test Affiliating Genes
1 Hyperlysinemia22 24 AASS

Anatomical Context for Hyperlysinemia

About this section

Animal Models for Hyperlysinemia or affiliated genes

About this section

Publications for Hyperlysinemia

About this section

Articles related to Hyperlysinemia:

(show all 24)
idTitleAuthorsYear
1
Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. (24847004)
2014
2
Genetic basis of hyperlysinemia. (23570448)
2013
3
Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia. (10775527)
2000
4
Familial hyperlysinemia in a patient presenting with progressive spastic paraparesis. (8797497)
1996
5
Hyperlysinemia and hyperammonemia]. (1904697)
1991
6
The prognosis of hyperlysinemia: an interim report. (6407303)
1983
7
Hyperlysinemia without clinical findings. (6798824)
1981
8
Hyperlysinemia with saccharopinuria due to combined lysine-ketoglutarate reductase and saccharopine dehydrogenase deficiencies presenting as cystinuria. (571908)
1979
9
Familial hyperlysinemia: enzyme studies, diagnostic methods, comments on terminology. (463877)
1979
10
Periodic hyperammonemia, hyperlysinemia, and homocitrullinuria associated with decreased argininosuccinate synthetase and arginase activities. (904980)
1977
11
Propionic acidemia and hyperlysinemia in a case with ornithine transcarbamylase (OTC) deficiency. (977722)
1976
12
Multiple enzyme defects in familial hyperlysinemia. (934735)
1976
13
Clinical and biochemical studies on periodic hyperammonemia with hyperlysinemia and homocitrullinuria. (982431)
1976
14
Effects of experimentally induced hyperlysinemia on maze learning in mice. (4795484)
1973
15
Excretion of hypusine by children and by patients with familial hyperlysinemia. (4753051)
1973
16
Ocular manifestations of familial hyperlysinemia. (5557172)
1971
17
Excretion of pipecolic acid by infants and by patients with hyperlysinemia. (5417004)
1970
18
Familial hyperlysinemia with lysine-ketoglutarate reductase insufficiency. (5796356)
1969
19
Paths of lysine degradation in patients with hyperlysinemia. (6074139)
1967
20
Further studies on hyperlysinemia associated with retardation. (6015892)
1967
21
A case of hyperlysinemia: biochemical and clinical observations. (6022933)
1967
22
Further studies of hyperlysinemia. (5928822)
1966
23
Hyperlysinemia associated with retardation. (5825685)
1965
24
HYPERLYSINEMIA. (14209691)
1964

Variations for Hyperlysinemia

About this section

Clinvar genetic disease variations for Hyperlysinemia:

5
id Gene Variation Type Significance SNP ID Assembly Location
1AASSNM_005763.3(AASS): c.2662+1_2662+5delGTAAGinsTTindelPathogenicrs587777121GRCh37Chr 7, 121717887: 121717891
2AASSNM_005763.3(AASS): c.874A> G (p.Ile292Val)single nucleotide variantPathogenicrs587777122GRCh37Chr 7, 121756707: 121756707
3AASSNM_005763.3(AASS): c.976_977delCA (p.Gln326Glufs)deletionPathogenicrs587777123GRCh37Chr 7, 121755194: 121755195
4AASSNM_005763.3(AASS): c.1925C> G (p.Ser642Ter)single nucleotide variantPathogenicrs587777124GRCh37Chr 7, 121731848: 121731848
5AASSNM_005763.3(AASS): c.194G> A (p.Arg65Gln)single nucleotide variantPathogenicrs587777125GRCh37Chr 7, 121773587: 121773587
6AASSNM_005763.3(AASS): c.1256T> G (p.Leu419Arg)single nucleotide variantPathogenicrs587777126GRCh37Chr 7, 121753194: 121753194
7AASSNM_005763.3(AASS): c.1601_1609delGTAAACAAG (p.Cys534_Ala871delinsTer)deletionPathogenicrs387906333GRCh37Chr 7, 121738550: 121738558

Expression for genes affiliated with Hyperlysinemia

About this section
Search GEO for disease gene expression data for Hyperlysinemia.

Pathways for genes affiliated with Hyperlysinemia

About this section

Pathways related to Hyperlysinemia according to GeneCards Suite gene sharing:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Fatty Acid Biosynthesis (WikiPathways)
Show member pathways
9.3
2
Show member pathways
8.1AASS, OTC, PC, PGD
3
Show member pathways
7.1AASS, DECR1, NADK2, OTC, PC, PGD

GO Terms for genes affiliated with Hyperlysinemia

About this section

Cellular components related to Hyperlysinemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1mitochondrial matrixGO:00057598.1AASS, DECR1, OTC, PC
2mitochondrionGO:00057397.3AASS, DECR1, NADK2, OTC, PC

Biological processes related to Hyperlysinemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cellular nitrogen compound metabolic processGO:00346419.2AASS, OTC
2oxidation-reduction processGO:00551149.0AASS, DECR1, PGD
3small molecule metabolic processGO:00442817.5AASS, DECR1, OTC, PC, PGD

Sources for Hyperlysinemia

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet